FindTrial
Sign In

Cancelled by the investigator A randomized controlled trial for vaginal versus sublingual misoprostol in early first-trimester medical abortion

A randomized controlled trial for comparing 800 ug vaginal versus 400 ug sublingual misoprostol in early first-trimester medical abortion.

Status
Unknown
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1900025763
Enrollment
Unknown
Registered
2019-09-07
Start date
2019-10-07
Completion date
Unknown
Last updated
2020-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medical abortion for early pregnancy

Interventions

Group 1:800-µg vaginal misoprostol
Group 2:400-ug sublingual misoprostol

Sponsors

University of Hong Kong, Shenzhen Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 38 Years

Inclusion criteria

Inclusion criteria: Patients with early pregnancy up to 63 days of gestational age (Ultrasound B make sure the gestational age). Single pregnancy. Volunteer to join the study.

Exclusion criteria

Exclusion criteria: Medical abortion contraindications; Aprevious attempt to terminate the pregnancy, abnormal uterine lesions such as fibroids or congenital malformations, medical disorders such as cardiac or hemorrhagic disease, and known hypersensitivity to any of the medications used.

Design outcomes

Primary

MeasureTime frame
complete abortion rate;—

Secondary

MeasureTime frame
the rate of side effects;—

Countries

China

Contacts

Public ContactDu Lipei

University of Hong Kong, Shenzhen Hospital

553706202@qq.com+86 18307556920

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026